On cross-priming of MHC class I-specific CTL: rule or exception?
Zinkernagel
Rolf M
RM
Institute for Experimental Immunology, University Hospital, Zurich, Switzerland. rolf.zinkernagel@pty.usz.ch
D000818:Animals; D020296:Animals, Congenic; D017951:Antigen Presentation / Q000276:immunology*; D000941:Antigens / Q000145:classification / Q000276:immunology*; D000951:Antigens, Neoplasm / Q000276:immunology; D000956:Antigens, Viral / Q000276:immunology; D003713:Dendritic Cells / Q000276:immunology; D006183:H-2 Antigens / Q000276:immunology; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D015778:Minor Histocompatibility Antigens / Q000276:immunology; D018448:Models, Immunological; D010047:Ovalbumin / Q000276:immunology; D010455:Peptides / Q000276:immunology; D051381:Rats; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D000941:Antigens; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D006183:H-2 Antigens; D015395:Histocompatibility Antigens Class I; D015778:Minor Histocompatibility Antigens; D010455:Peptides; D010047:Ovalbumin